Educating the public on the benefits of medical cannabis is essential for a successful program. More states are seeing the value in medical marijuana as the days go by and new developments across the nation show barriers being broken and systems created for innovation in patient care. Companies like AGRiMED are on the rise and using our agricultural and medical knowledge to bring safe and effective products to patients. State and local government officials are also coming along to include promises of support or implementation of medical cannabis programs in their campaigns. Though there is a rapidly growing population of people in favor of shifting America’s pharmaceutical industry, the federal government’s stagnant policies often stand as the elephant in the dispensary. It can be very confusing at times for example; in Washington DC a 2015 law decriminalizing marijuana makes it legal to possess small amounts of marijuana, but U.S. attorney Jeff Sessions is an advocate for harshening offenses on all drugs. Even academia, the conversation of cannabis can only go so far, despite what laws are in the state. Not only is the possession, medical or not still punishable by universities, but few students actually have access to courses involving the medical use of cannabis plants. “Medical education needs to catch up to marijuana legislation,” said senior author Laura Jean Bierut, MD, the Alumni Endowed Professor of Psychiatry at Washington University. With a low number of researchers, physicians, and other professionals gaining experience in the field due to lack of access, it becomes difficult to conduct more experiments and gain new information.
In Pennsylvania, an adult patient must complete three steps receive a medical cannabis card. They must:
- Discuss medical cannabis with your doctor/licensed practitioner.
- Get a recommendation from your doctor that medical cannabis is right for you.
- Apply for a department of Health medical cannabis ID card.
When fully implemented, the Medical Marijuana Program in Pennsylvania will provide access to medical cannabis for patients with a serious medical condition through a safe and effective method of distribution that balances patient need for access to the latest treatments with patient care and safety. The Medical Marijuana Program will also promote high quality research into the efficacy of medical marijuana in treating a patient’s serious medical condition. AGRiMED is committed to developing cannabis formulations for individual needs of the patient and educating patients on the differences of treatment options.
Although 17 serious medical conditions are covered under Act 16 in Pennsylvania, these following conditions are not included in Act 16:
- Iron deficiency
- Eating disorders, including anorexia
In order to be able to prescribe cannabis products to patients as a physician, they must first register online and some states require them to participate in learning sessions. AGRiMED plans to take education seriously. We will be providing information for patients, doctors, and future workers in the medical cannabis field along with educating patients online. In Pennsylvania and more locations to come, AGRiMED will be spreading literature, hosting information sessions and building relations with students, starting with the first HBCU Lincoln University. Teaching the benefits and procedures of producing quality cannabis products is needed much more on the academic level. These eager students will be the future of the industry and AGRiMED recognizes that. We are dedicated to influencing knowledge and reaching everyone who will potentially be involved in the program. Follow us on social media for upcoming events focused on educating the public on the benefits of medical cannabis.